RSV testing among infants has increased since 2015, with significant growth post-COVID-19, yet outpatient testing remains low. The study analyzed 20,752 bronchiolitis encounters across four healthcare ...

Immunisation with nirsevimab reduced bronchiolitis-related hospitalisations among infants younger than 3 months who visited the emergency department (ED), according to a new study. Nirsevimab also ...

Medications and management processes known to be ineffective or harmful in infants with bronchiolitis were tossed in favor of targeted interventions in hospitals, resulting in improvements in ...

Please provide your email address to receive an email when new articles are posted on . Compared with all pediatric hospitalizations, transfer rates for bronchiolitis were higher. Infants on public ...

The mainstays of treatment are ensuring adequate rest, hydration, and oxygenation. A humidifier can be used to help loosen sticky mucus. The decision to admit a child to the hospital is made on the ...

Bronchiolitis is a leading cause of infant hospitalizations and is associated with significant health care resource utilization. Effective therapies are limited, leading to substantial practice ...

Babies discharged from the emergency department (ED) for bronchiolitis saw mixed benefits from enhanced nasal suctioning, a randomized trial found. Additional resource use -- a composite of ...

Bronchiolitis is the leading cause of infant hospitalizations in the United States and Europe, and almost one third of these patients go on to develop asthma later in childhood. But a multinational ...

Bronchiolitis often affects infants under 2 and is usually caused by the respiratory syncytial virus (RSV). Bronchitis can happen at any age and involves inflammation due to viral infections like ...

Evidence-based reviews suggest limited use of diagnostic testing and treatment modalities in the management of bronchiolitis. Although most studies have shown a lack of efficacy for the use of ...